Login / Signup

State of the European Union's early notification obligation for drug shortages: enforcement and compliance in eight European countries (2020-2022).

Reko RavelaMarja AiraksinenAlan Lyles
Published in: Journal of pharmaceutical policy and practice (2023)
The EU regulatory requirement adopted in 2019 for early notification of drug shortages was unsuccessful in the eight countries having openly available statistics for follow-up. The national policy experiment in Finland with a progressive notification fee seemed to increase compliance with early notification.
Keyphrases
  • multiple sclerosis
  • healthcare
  • public health
  • transcription factor
  • emergency department
  • adverse drug